Orthofix Medical (OFIX) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.63% |
| Dec 31, 2025 | 36.39% |
| Sep 30, 2025 | -34.34% |
| Jun 30, 2025 | 17.81% |
| Mar 31, 2025 | -24.76% |
| Dec 31, 2024 | -26.58% |
| Sep 30, 2024 | 19.80% |
| Jun 30, 2024 | -96.55% |
| Mar 31, 2024 | -83.84% |
| Dec 31, 2023 | -26.84% |
| Sep 30, 2023 | -61.54% |
| Jun 30, 2023 | -87.86% |
| Mar 31, 2023 | -52.81% |
| Dec 31, 2022 | -44.84% |
| Sep 30, 2022 | -37.66% |
| Jun 30, 2022 | -14.33% |
| Mar 31, 2022 | -11.10% |
| Dec 31, 2021 | -56.13% |
| Sep 30, 2021 | -27.78% |
| Jun 30, 2021 | 18.05% |
| Mar 31, 2021 | -26.58% |
| Dec 31, 2020 | -44.79% |
| Sep 30, 2020 | 51.57% |
| Jun 30, 2020 | -47.80% |
| Mar 31, 2020 | 39.16% |
| Dec 31, 2019 | 33.39% |
| Jun 30, 2019 | -16.72% |
| Mar 31, 2019 | 19.67% |
| Dec 31, 2018 | 22.81% |
| Sep 30, 2018 | 41.71% |
| Jun 30, 2018 | 18.25% |
| Mar 31, 2018 | -2.09% |
| Dec 31, 2017 | -41.52% |
| Sep 30, 2017 | -1.08% |
| Jun 30, 2017 | -10.78% |
| Mar 31, 2017 | -18.75% |
| Dec 31, 2016 | -19.52% |
| Sep 30, 2016 | 0.73% |
| Jun 30, 2016 | -27.83% |
| Mar 31, 2016 | 16.04% |
| Dec 31, 2015 | -24.21% |
| Sep 30, 2015 | -15.81% |
| Jun 30, 2015 | -19.73% |